nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Glucose tolerance impaired—Octreotide—thymus cancer	0.108	0.124	CcSEcCtD
Testosterone Propionate—Clotting—Octreotide—thymus cancer	0.0811	0.0934	CcSEcCtD
Testosterone Propionate—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0425	0.0489	CcSEcCtD
Testosterone Propionate—Coagulopathy—Octreotide—thymus cancer	0.0372	0.0429	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Octreotide—thymus cancer	0.0349	0.0402	CcSEcCtD
Testosterone Propionate—Breast pain—Octreotide—thymus cancer	0.0332	0.0382	CcSEcCtD
Testosterone Propionate—Jaundice cholestatic—Octreotide—thymus cancer	0.033	0.038	CcSEcCtD
Testosterone Propionate—Gynaecomastia—Octreotide—thymus cancer	0.0259	0.0298	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Octreotide—thymus cancer	0.0217	0.025	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.021	0.0242	CcSEcCtD
Testosterone Propionate—Irritability—Octreotide—thymus cancer	0.0201	0.0231	CcSEcCtD
Testosterone Propionate—Dysuria—Octreotide—thymus cancer	0.017	0.0196	CcSEcCtD
Testosterone Propionate—Weight increased—Octreotide—thymus cancer	0.0165	0.019	CcSEcCtD
Testosterone Propionate—Haematuria—Octreotide—thymus cancer	0.0155	0.0178	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Octreotide—thymus cancer	0.0153	0.0177	CcSEcCtD
Testosterone Propionate—UGT1A1—hematopoietic system—thymus cancer	0.0142	0.108	CbGeAlD
Testosterone Propionate—Immune system disorder—Octreotide—thymus cancer	0.0131	0.0151	CcSEcCtD
Testosterone Propionate—Alopecia—Octreotide—thymus cancer	0.0129	0.0148	CcSEcCtD
Testosterone Propionate—Mental disorder—Octreotide—thymus cancer	0.0127	0.0147	CcSEcCtD
Testosterone Propionate—Malnutrition—Octreotide—thymus cancer	0.0127	0.0146	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Octreotide—thymus cancer	0.0118	0.0135	CcSEcCtD
Testosterone Propionate—Malaise—Octreotide—thymus cancer	0.0114	0.0132	CcSEcCtD
Testosterone Propionate—COMT—hematopoietic system—thymus cancer	0.0113	0.086	CbGeAlD
Testosterone Propionate—Hypertension—Octreotide—thymus cancer	0.0109	0.0126	CcSEcCtD
Testosterone Propionate—Myalgia—Octreotide—thymus cancer	0.0108	0.0124	CcSEcCtD
Testosterone Propionate—Arthralgia—Octreotide—thymus cancer	0.0108	0.0124	CcSEcCtD
Testosterone Propionate—Anxiety—Octreotide—thymus cancer	0.0107	0.0124	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0107	0.0123	CcSEcCtD
Testosterone Propionate—Discomfort—Octreotide—thymus cancer	0.0107	0.0123	CcSEcCtD
Testosterone Propionate—Oedema—Octreotide—thymus cancer	0.0103	0.0119	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Octreotide—thymus cancer	0.0103	0.0119	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Octreotide—thymus cancer	0.0101	0.0117	CcSEcCtD
Testosterone Propionate—Skin disorder—Octreotide—thymus cancer	0.01	0.0116	CcSEcCtD
Testosterone Propionate—CYP17A1—thyroid gland—thymus cancer	0.0099	0.0752	CbGeAlD
Testosterone Propionate—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00942	0.0108	CcSEcCtD
Testosterone Propionate—Insomnia—Octreotide—thymus cancer	0.00935	0.0108	CcSEcCtD
Testosterone Propionate—Paraesthesia—Octreotide—thymus cancer	0.00928	0.0107	CcSEcCtD
Testosterone Propionate—Dyspnoea—Octreotide—thymus cancer	0.00922	0.0106	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Octreotide—thymus cancer	0.00892	0.0103	CcSEcCtD
Testosterone Propionate—Fatigue—Octreotide—thymus cancer	0.00891	0.0103	CcSEcCtD
Testosterone Propionate—Pain—Octreotide—thymus cancer	0.00884	0.0102	CcSEcCtD
Testosterone Propionate—COMT—cardiac atrium—thymus cancer	0.0086	0.0653	CbGeAlD
Testosterone Propionate—Feeling abnormal—Octreotide—thymus cancer	0.00852	0.00981	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Octreotide—thymus cancer	0.00845	0.00973	CcSEcCtD
Testosterone Propionate—COMT—pituitary gland—thymus cancer	0.0084	0.0638	CbGeAlD
Testosterone Propionate—AR—hematopoietic system—thymus cancer	0.00828	0.063	CbGeAlD
Testosterone Propionate—Urticaria—Octreotide—thymus cancer	0.00821	0.00946	CcSEcCtD
Testosterone Propionate—Abdominal pain—Octreotide—thymus cancer	0.00817	0.00941	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Octreotide—thymus cancer	0.00762	0.00877	CcSEcCtD
Testosterone Propionate—AR—epithelium—thymus cancer	0.00757	0.0575	CbGeAlD
Testosterone Propionate—Asthenia—Octreotide—thymus cancer	0.00742	0.00854	CcSEcCtD
Testosterone Propionate—Pruritus—Octreotide—thymus cancer	0.00731	0.00842	CcSEcCtD
Testosterone Propionate—COMT—bone marrow—thymus cancer	0.00726	0.0551	CbGeAlD
Testosterone Propionate—COMT—thyroid gland—thymus cancer	0.00724	0.055	CbGeAlD
Testosterone Propionate—Diarrhoea—Octreotide—thymus cancer	0.00707	0.00814	CcSEcCtD
Testosterone Propionate—Dizziness—Octreotide—thymus cancer	0.00684	0.00787	CcSEcCtD
Testosterone Propionate—COMT—lung—thymus cancer	0.00657	0.05	CbGeAlD
Testosterone Propionate—Vomiting—Octreotide—thymus cancer	0.00657	0.00757	CcSEcCtD
Testosterone Propionate—Rash—Octreotide—thymus cancer	0.00652	0.0075	CcSEcCtD
Testosterone Propionate—Dermatitis—Octreotide—thymus cancer	0.00651	0.0075	CcSEcCtD
Testosterone Propionate—Headache—Octreotide—thymus cancer	0.00648	0.00746	CcSEcCtD
Testosterone Propionate—AR—cardiac atrium—thymus cancer	0.00629	0.0478	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—thymus cancer	0.00615	0.0467	CbGeAlD
Testosterone Propionate—AR—pituitary gland—thymus cancer	0.00614	0.0467	CbGeAlD
Testosterone Propionate—Nausea—Octreotide—thymus cancer	0.00614	0.00707	CcSEcCtD
Testosterone Propionate—AR—lymphoid tissue—thymus cancer	0.00583	0.0443	CbGeAlD
Testosterone Propionate—AR—thyroid gland—thymus cancer	0.0053	0.0403	CbGeAlD
Testosterone Propionate—AR—lung—thymus cancer	0.00481	0.0366	CbGeAlD
Testosterone Propionate—COMT—lymph node—thymus cancer	0.0045	0.0342	CbGeAlD
Testosterone Propionate—AR—lymph node—thymus cancer	0.00329	0.025	CbGeAlD
